Insider Transactions in Q2 2024 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 28
2024
|
Jonathan Young Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.42%
|
$20,216
$19.94 P/Share
|
Jun 28
2024
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.18%
|
$20,216
$19.94 P/Share
|
Jun 28
2024
|
Patrick Lamy Senior VP, Commercial Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
221
+1.16%
|
$4,199
$19.94 P/Share
|
Jun 28
2024
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+1.38%
|
$20,216
$19.94 P/Share
|
Jun 28
2024
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.58%
|
$20,216
$19.94 P/Share
|
Jun 11
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,825
-3.64%
|
$62,150
$22.64 P/Share
|
Jun 11
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,516
-0.99%
|
$55,352
$22.64 P/Share
|
Jun 11
2024
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,380
-1.3%
|
$52,360
$22.64 P/Share
|
Jun 11
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,831
-5.7%
|
$62,282
$22.64 P/Share
|
Jun 11
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
7,894
-1.34%
|
$173,668
$22.64 P/Share
|
Jun 11
2024
|
Patrick Lamy Senior VP, Commercial Strategy |
SELL
Open market or private sale
|
Direct |
569
-2.97%
|
$12,518
$22.64 P/Share
|
Jun 03
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.94%
|
$95,000
$19.29 P/Share
|
May 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.9%
|
$100,000
$20.15 P/Share
|
Apr 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
400
-0.15%
|
$10,000
$25.02 P/Share
|
Apr 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,600
-1.71%
|
$110,400
$24.33 P/Share
|